2-benzyl-N-acetyltryptamine,
luzindole,
N 0774,
N-0774,
luzindole,
117946-91-5,
N-Acetyl-2-benzyltryptamine,
2-Benzyl-N-acetyltryptamine,
N-Acetyl-2-benzyl-tryptamine,
N 0774,
MFCD00672498,
N-0774,
N-[2-(2-benzyl-1H-indol-3-yl)ethyl]acetamide,
N-[2-[2-(Phenylmethyl)-1H-indol-3-yl]ethyl]acetamide,
N-(2-(2-benzyl-1H-indol-3-yl)ethyl)acetamide,
Tocris-0877,
Luzindole, >=90%,
AC1L3U3V,
AMOT0032,
CHEMBL286615,
GTPL1363,
SCHEMBL4869000,
ZINC3941,
BDBM85065,
CHEBI:93173,
CTK8E7069,
DTXSID40151969,
CHEBI:131788,
Acetamide, N-(2-(2-(phenylmethyl)-1H-indol-3-yl)ethyl)-,
HMS3266N04,
HMS3675B10,
7354AH,
BN0311,
PDSP1_001788,
PDSP2_001771,
AKOS024458674,
NSC_122162,
TRA0042414,
NCGC00024838-01,
NCGC00024838-02,
AN-25006,
ZB000552,
N-{2-[2-benzylindol-3-yl]ethyl}acetamide,
RT-013606,
AM20020263,
B6483,
CAS_117946-91-5,
FT-0628053,
L0316,
ST50405851,
KS-00001828,
L000360,
SR-01000597433,
J-003685,
N-[2-(2-Benzyl-1H-indol-3-yl)-ethyl]-acetamide,
SR-01000597433-1,
BRD-K67013324-001-01-5,
C19H20N2O,
CID122162,
N0774,
C057154,